VEGF induces vascular abnormalities and augments the immune suppressive activity of MDSCs, Tregs, and tumor-associated macrophages in lung cancer, colon cancer, and hepatocellular carcinoma, which in turn drives angiogenesis to suppress antitumor immunity [83]. Here, VEGFA is linked to colonic neoplasm.